USD $117.20
Products matching the full generic name: Trifluridine and Tipiracil
Comtripsy, equivalent to Lonsurf, is a prescription medication primarily used in the treatment of certain types of cancer. It is a combination of two active ingredients, trifluridine and tipiracil, which work together to interfere with the growth and spread of cancer cells.
Comtripsy contains trifluridine, which is incorporated into the DNA of cancer cells, disrupting their function and growth. Tipiracil enhances the effectiveness of trifluridine by preventing its breakdown, ensuring higher concentrations remain active in the body for longer periods.
Comtripsy is prescribed for patients with colorectal cancer that has spread to other parts of the body and who have already been treated with other chemotherapy drugs. It is also considered for patients with gastric cancer after other treatments have failed.
Comtripsy is taken orally in the form of tablets. It is usually administered in specific cycles, as determined by a healthcare provider, and should be taken with food to ensure optimal absorption.
Common side effects of Comtripsy may include fatigue, nausea, decreased appetite, diarrhea, and abdominal pain. Patients should consult their healthcare provider for a complete list of possible side effects and any concerns they may have.
Patients should inform their healthcare provider of any allergies, pre-existing conditions, or other medications they are taking before starting Comtripsy. It is important to follow the prescribed dosage and schedule to minimize potential risks and interactions.
Comtripsy should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children and pets.
For further details about Comtripsy, including its usage and comprehensive safety information, patients should consult their healthcare provider or pharmacist. Additional information can also be found in the medication guide provided with the prescription.
Health Guides